Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 4 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 27% ± 3% | |
| astrocyte | 4 studies | 20% ± 4% | |
| glutamatergic neuron | 4 studies | 29% ± 12% | |
| GABAergic neuron | 3 studies | 28% ± 7% | |
| basal cell | 3 studies | 24% ± 1% | |
| oligodendrocyte | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 718.86 | 226 / 226 | 100% | 6.44 | 406 / 406 |
| brain | 100% | 691.76 | 2638 / 2642 | 100% | 7.00 | 705 / 705 |
| thymus | 100% | 939.84 | 653 / 653 | 100% | 10.61 | 604 / 605 |
| prostate | 100% | 1021.47 | 245 / 245 | 100% | 8.38 | 501 / 502 |
| uterus | 100% | 954.05 | 170 / 170 | 100% | 9.28 | 458 / 459 |
| bladder | 100% | 766.48 | 21 / 21 | 100% | 7.75 | 502 / 504 |
| lung | 100% | 712.74 | 578 / 578 | 99% | 6.08 | 1148 / 1155 |
| intestine | 100% | 759.51 | 966 / 966 | 99% | 5.71 | 522 / 527 |
| skin | 100% | 850.26 | 1809 / 1809 | 99% | 6.21 | 467 / 472 |
| esophagus | 100% | 761.71 | 1445 / 1445 | 99% | 4.35 | 181 / 183 |
| breast | 100% | 1036.35 | 459 / 459 | 99% | 8.83 | 1105 / 1118 |
| ovary | 100% | 896.74 | 180 / 180 | 99% | 5.09 | 425 / 430 |
| pancreas | 99% | 404.02 | 326 / 328 | 99% | 7.97 | 177 / 178 |
| adrenal gland | 100% | 696.98 | 258 / 258 | 99% | 6.23 | 227 / 230 |
| kidney | 100% | 785.72 | 89 / 89 | 98% | 5.86 | 881 / 901 |
| stomach | 100% | 584.42 | 359 / 359 | 97% | 4.70 | 278 / 286 |
| adipose | 100% | 832.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 9.96 | 29 / 29 |
| spleen | 100% | 901.72 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 6.86 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.28 | 1 / 1 |
| blood vessel | 100% | 707.61 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 405.10 | 854 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 333.26 | 791 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 5.59 | 78 / 80 |
| peripheral blood | 96% | 479.55 | 894 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000390 | Biological process | spliceosomal complex disassembly |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0005681 | Cellular component | spliceosomal complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | DNAJC17 |
| Protein name | DnaJ homolog subfamily C member 17 DnaJ heat shock protein family (Hsp40) member C17 |
| Synonyms | |
| Description | FUNCTION: May negatively affect PAX8-induced thyroglobulin/TG transcription. . |
| Accessions | ENST00000561018.5 H0YLQ7 ENST00000559238.5 ENST00000560065.6 S4R343 H0YLV4 ENST00000560645.5 ENST00000627802.1 ENST00000559310.3 Q9NVM6 ENST00000220496.9 H0YK99 |